Search
for
Sort by
Research 451–480 of 1000+
- Skin as a Window to Endocrine Dysfunction: Dermatological and Metabolic Interactions in Polycystic Ovary Syndrome
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products
- Dermatological adverse events with taxane chemotherapy
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Dermatological drugs, topical agents, and cosmetics
- Hypersensitivity Diseases
- Microneedle-Based Approaches for Skin Disease Treatment
- Cutaneous Clues to Metabolic Dysfunction: Dermatological Manifestations of Diabetes and Insulin Resistance in Clinical Practice
- Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin Aging
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Dermatologia e Procedimentos Estéticos Ed. XVIII
- What does acne genetics teach us about disease pathogenesis?
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Approach to Patients with Suspected Rheumatic Disease
- Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Post COVID Alopecia in the Indian Subcontinent - A Harbinger of Disease Severity
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Protein-Losing Enteropathy, Anasarca and Dermatological Manifestations on People of Advanced Age: Don't Overlook the Diagnostic Hypothesis of a Cronkhite Canada Syndrome
- Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases?
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Serum 25-Hydroxy Vitamin D Level in Patients with Alopecia Areata and Its Relationship with Severity of the Disease
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo